HPV16 E6-G350 gene expression promotes proliferation and inhibits apoptosis in cervical cancer C33A cells

Zhenzhen Pan,Yuning Song,Xiangyi Zhe,Wenli Wu,Jing Xu,Hang Xu,Wanchao Xin,Bin Zhang,Huizhen Xin,Dongdong Cao,Zemin Pan
DOI: https://doi.org/10.13880/j.cnki.65-1174/n.2018.05.007
2018-01-01
Abstract:Objective To analyze the relationship between HPV16 E6 gene polymorphism site and the development of cervical cancer. Methods HPV16 E6-T295/T350-GV230 and HPV16 E6-T295/G350-GV230 was stable transfected in human cervical cancer C33 A cells. HPV16 E6 protein expression was confirmed by indirect immunofluorescence assay. CCK8 assay and clonogenic assay was used for analyzing C33 A cells proliferation. C33 A cells apoptosis was analyzed by fluorescence activated cell sorting (FACS) experiment. Results SPSS 17.0 statistical software was used for statistical data processing. P<0.05 was considered statistically significant. Cell proliferation and inhibit apoptosis was promoted by HPV 16 E6 T295/T350 and T295/G350 GV230 eukaryotic expression vector transfected into cervical cancer C33 A cells. The effect of T295/G350-GV230 was stronger than T295/T350-G V230, the difference was statistically significant (P<0.05). Conclusion Meanwhile The proliferation and inhibit apoptosis of cervical cancer cells also promoted by HPV16 E6 T295/T350 of European prototype and HPV16 E6 T295/G350 of European mutant. It can be concluded that the effect of HPV16 E6 T295/G350 of European mutation promoting cancer is stronger than those of HPV 16 E6 T295/T350 of European prototype.
What problem does this paper attempt to address?